28101-74-8 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Amino-DL-Phenylalanine is used as a chiral building block for the synthesis of pharmaceutical drugs. Its unique structure allows for the creation of various drug molecules with specific therapeutic properties.
Used in the Treatment of Neurological Disorders:
In the medical field, 3-Amino-DL-Phenylalanine is utilized as a potential treatment for various neurological disorders. Its role in modulating neurotransmitter levels and potentially influencing brain function makes it a candidate for further research and development in this area.
Used in Oncology Research:
3-Amino-DL-Phenylalanine is also used in cancer research as a potential therapeutic agent. Its effects on certain types of cancer cells are of interest, and ongoing studies aim to understand its mechanisms of action and potential synergistic effects with existing cancer treatments.
Used in the Production of Other Chemicals:
Beyond its direct applications, 3-Amino-DL-Phenylalanine serves as a precursor in the production of other chemicals, contributing to a range of industrial applications beyond healthcare and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 28101-74-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,1,0 and 1 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 28101-74:
(7*2)+(6*8)+(5*1)+(4*0)+(3*1)+(2*7)+(1*4)=88
88 % 10 = 8
So 28101-74-8 is a valid CAS Registry Number.
28101-74-8Relevant academic research and scientific papers
Immunomodulatory peptides
-
, (2014/12/12)
The invention relates to peptides derivatized with a hydrophilic polymer which, in some embodiments, bind to human FcRn and inhibit binding of the Fc portion of an IgG to an FcRn, thereby modulating serum IgG levels. The disclosed compositions and methods may be used in some embodiments, for example, in treating autoimmune diseases and inflammatory disorders. The invention also relates, in further embodiments, to methods of using and methods of making the peptides of the invention.
